NCT07470840 2026-03-24SBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell CarcinomaFujian Cancer HospitalPhase 2 Not yet recruiting27 enrolled
NCT07363512 2026-01-23Efficacy and Safety of Radiotherapy Combined With Tislelizumab and Anlotinib in the Treatment of Hepatocellular Carcinoma Complicated With Portal Vein Tumor ThrombusHenan Cancer HospitalPhase 2 Not yet recruiting27 enrolled